HDAC8 inhibition suppresses BC cell migration induced by TGF-β1 while SIRT7 knockdown attenuates this effect in vivo and in vitro, implicating that HDAC8 inhibition suppresses metastasis by enhancing SIRT7 transcription [57]. Here, HDAC8 is linked to breast cancer.